gadolinium dtpa has been researched along with aziridine in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (aziridine) | Trials (aziridine) | Recent Studies (post-2010) (aziridine) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 403 | 1 | 153 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Dong, J; Jiang, B; Liu, M; Lu, B; Pei, R; Tong, X; Zhang, H; Zhang, K; Zheng, H | 1 |
1 other study(ies) available for gadolinium dtpa and aziridine
| Article | Year |
|---|---|
Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
Topics: Animals; Aziridines; Cell Line, Tumor; Chitosan; Contrast Media; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Probe Techniques; Neoplasms, Experimental; Reproducibility of Results; Sensitivity and Specificity | 2016 |